Celldex Therapeutics | CLDX - Passività Correnti





Passività Correnti Cambiamento Data
AbbVie USD 41.64B 458M 2026-06
Agenus USD 231.82M 17.42M 2026-06
Amgen USD 25.5B 547M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Celldex Therapeutics USD 61.32M 9.85M 2026-06
Glaxosmithkline GBP 22.43B 6.39B 2026-03
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Northwest Biotherapeutics USD 82.97M 4.93M 2026-03
Pfizer USD 32.65B 1.7B 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28.85B 846M 2026-06